Pradaxa
PradaxaTM has been linked to excessive internal bleeding and heart attacks. In January of 2012, the manufacturer of Pradaxa confirmed at least 260 deaths.
Patients with atrial fibrillation (AF) should not stop taking Pradaxa before speaking with their healthcare professionals. Stopping use of blood thinning medication can increase the risk of strokes.
FDA Investigation
In October 2010 the FDA approved Pradaxa to help prevent strokes in patients with non-valvular atrial fibrillation. The FDA is now investigating reports of potentially fatal bleeding events and deaths in patients taking Pradaxa.
Symptoms
-
Unusual bleeding from the gums
-
Frequent nose bleeds
-
Pink or brown urine
-
Coughing up blood or blood clots
-
Vomiting blood or substance that looks like coffee grounds
-
Unexplained bruises that grow over time
-
Red or black stool that looks like tar
-
Unusually heavy menstrual or vaginal bleeding
-
Severe, uncontrolled bleeding
If you or a loved one suffered or continues to suffer from complications due to Pradaxa, our experienced attorneys are here to help. Please call or submit the form today to determine your next step during this difficult time.